Oxford publishes peer-reviewed COVID-19 vaccine results
16 December, 2020Interim results of the University of Oxford's COVID-19 vaccine Phase 3 trials find that the vaccine protects against symptomatic disease in 70% of cases on average.
Mobile CSSD provides flexible on-site capacity
15 December, 2020A mobile or modular on-site sterilisation department can ensure continuity during periods of refurbishment or exceptional demand.
UK hospitals deploy Aus-designed pop-up patient isolation rooms
08 December, 2020An instant patient isolation room that can be deployed in five minutes is being used by hospitals throughout the UK to isolate patients with COVID-19.
Research reveals gaps in adult pertussis vaccination
03 December, 2020Older Australians may be missing out on protection against pertussis because GPs tend to focus on vaccinating those in close contact with young children.
How long until the leading vaccines make it to market?
02 December, 2020 by Amy SarcevicPfizer and BioNTech may face major hurdles in getting their vaccine to market, despite recently being touted as winners of the COVID-19 vaccine race.
Research reveals likely locations of next pandemic
27 November, 2020An international team of human and animal health experts has identified areas at risk of harbouring the conditions that may lead to the next pandemic.
AstraZeneca vaccine candidate
26 November, 2020 by Nicholas Wood, University of Sydney for The ConversationAstraZeneca's results signal more good vaccine news — but efficacy is only the beginning of the story.
Monash superbug project to mobilise genomics, digital health and AI
23 November, 2020The innovative project will integrate genomics, electronic healthcare data and AI technologies to address antimicrobial resistance in the healthcare system.
Interim results: Moderna vaccine candidate stable and effective
20 November, 2020Interim analysis of Moderna's Phase 3 study of mRNA-1273 finds that the COVID-19 vaccine candidate has an efficacy of 94.5% and remains stable at -20°C for up to six months.
Drug-resistant UTIs: the canary in the coalmine
19 November, 2020One of the world's most common infections will cost Australia more than $1 billion a year within the next decade if nothing is done to stop the rise of antibiotic-resistant bacteria.
How did Royal Melbourne Hospital curb its COVID-19 outbreak?
16 November, 2020Reported to have endured the largest institutional outbreak of COVID-19 in healthcare workers in Australia, the RMH's multidimensional response has been examined.
Vaccinate potential superspreaders first, researchers say
13 November, 2020Macquarie University researchers have unveiled a strategy that models who should be vaccinated first.
Australian experts respond to Pfizer vaccine announcement
12 November, 2020Pfizer and BioNTech have issued a press release, announcing that their vaccine candidate is more than 90% effective in preventing COVID-19.
Australia secures two more vaccine candidates
06 November, 2020The Australian Government has secured two more potential coronavirus vaccines for Australia.
COVID-19 reinfections — what do we know so far?
03 November, 2020 by Amy SarcevicDr Larisa Labzin has helped demystify the topic of COVID-19 reinfections — highlighting what researchers now know for sure, what they think may be true and which areas they still have no idea about.
